Q4 2021 Results slide image

Q4 2021 Results

Participants Company overview Pharmaceuticals Financial performance Appendix Oncology Financial review Conclusion Innovation: Pipeline overview Appendix Innovation: Clinical trials 50 Investor Relations | Q4 2021 Results NOVARTIS | Reimagining Medicine
View entire presentation